IGF2BP1 and esophageal squamous cell carcinoma: The present study reveals for the first time that elevated IGF2BP1 plays a pivotal role in the invasion and migration of ESCC cells by activating the IHNBA-Smad2/3 signaling pathway, providing a promising and attractive target for ESCC patients with high expression of IGF2BP1.